The capacity of blood centers around the world was leveraged to carry out large scale SARS-CoV-2 seroprevalence studies to inform public health. While blood donor research remains integral to informing transfusion and blood center policy, the potential to also contribute to public health has gained traction. Prior to the pandemic there were examples of data generated from donor testing informing public health policy. Some countries, notably Denmark, had established donor studies for public health purposes. Since the start of the pandemic, planning is now underway in many countries to add value from blood collection agencies by contributing to public health research. In this session the breadth of approaches to donors contributing to public health research will be explored. These include examples from the USA, Europe, and elsewhere, as well as current activities of the Surveillance, Risk Assessment and Policy subgroup of the Transfusion Transmissible Infectious Diseases Working Party, International Society for Blood Transfusion.
Describe examples of how blood donors can contribute to public health research and policy
Discuss the strengths and limitations of blood center research to inform public health policy
Compare the international experience to orient research towards gaps blood centers can fill